At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 21, 2026 at 16:13 ET
A two-insider cluster at Medpace shows net selling of $4.69M, dominated by Director Fred B. Davenport Jr.'s open-market sale of 7,283 shares for $4.41M at $606.15, following the exercise of multiple derivative tranches. President & CEO August J. Troendle also sold 458 shares for $275K. The total open-market sale value of ~$4.69M represents ~0.027% of Medpace's $17.1B market cap, which is well below the 0.1% materiality threshold, indicating routine portfolio management rather than a bearish signal. The derivative exercises by Davenport are non-cash events that do not drive sentiment. The cluster is neutral with low impact, as the dollar amounts are trivial relative to company size and insider sales are generally weak predictors per academic literature.
- Director Fred B. Davenport Jr. sold 7,283 shares open-market for $4.41M at $606.15 on 2026-08-19, following derivative exercises of 13,166 shares across multiple tranches.
- President & CEO August J. Troendle sold 458 shares open-market for $275K at $600.39 on 2026-08-13.
- Total open-market sale value of ~$4.69M is only ~0.027% of Medpace's $17.1B market cap, well below the 0.1% materiality threshold.
- The derivative exercises by Davenport (totaling $880K in exercise costs and $0 for non-cash tranches) are non-cash or cashless events and do not represent economic selling.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access